SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sanofi India informs about disclosures of related party transactions

24 Aug 2021 Evaluate

Sanofi India has informed that the unaudited financial results of the Company for the quarter and half year ended 30th June 2021 were approved by the Board of Directors of the Company at its meeting held on 27th July 2021 and published on 29th July 2021. Pursuant to Regulation 23(9) of Listing Regulations, the company has enclosed the disclosures of related party transactions for the half year ended 30th June 2021 in the format specified in the applicable accounting standards.

The above information is a part of company’s filings submitted to BSE.

Sanofi India Share Price

3444.30 -57.10 (-1.63%)
23-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1679.85
Dr. Reddys Lab 1333.05
Cipla 1305.85
Zydus Lifesciences 947.10
Lupin 2340.20
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×